133 related articles for article (PubMed ID: 34974464)
1. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
Ülger Y; Delik A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
[No Abstract] [Full Text] [Related]
3. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic syndromes in hepatocellular carcinoma: a review.
Ong Y; Huey CWT; Shelat VG
Expert Rev Gastroenterol Hepatol; 2022 May; 16(5):449-471. PubMed ID: 35649187
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytosis as a Rare Paraneoplastic Syndrome Occurring in Hepatocellular Carcinoma: A Case Report.
Abbas H; Hanif S; Tariq H; Chilimuri S
Gastroenterology Res; 2019 Apr; 12(2):96-99. PubMed ID: 31019620
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.
Qu Q; Wang S; Chen S; Zhou L; Rui JA
Am Surg; 2014 Feb; 80(2):191-6. PubMed ID: 24480222
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
[TBL] [Abstract][Full Text] [Related]
8. [A case of hepatocellular carcinoma with paraneoplastic hypercholesterolemia, thrombocytosis and hypoglycemia].
Inomata E; Sohda T; Nakane H; Morihara D; Hirose O; Kitamura Y; Iwata K; Irie M; Takeyama Y; Watanabe H; Sakisaka S
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1231-5. PubMed ID: 17675826
[TBL] [Abstract][Full Text] [Related]
9. Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Chang FY; Lee SD; Lui WY; Chiang JH
J Gastroenterol Hepatol; 1999 Aug; 14(8):807-10. PubMed ID: 10482434
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma.
Chang PE; Ong WC; Lui HF; Tan CK
ISRN Oncol; 2013; 2013():684026. PubMed ID: 24396608
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
Luo JC; Hwang SJ; Wu JC; Li CP; Hsiao LT; Lai CR; Chiang JH; Lui WY; Chang FY; Lee SD
Cancer; 1999 Sep; 86(5):799-804. PubMed ID: 10463978
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
Hwang SJ; Lee SD; Wu JC; Chang CF; Lu CL; Tsay SH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):262-9. PubMed ID: 7518732
[TBL] [Abstract][Full Text] [Related]
14. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
15. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
16. Histological differentiation predicts post-liver transplantation survival time.
Li WX; Li Z; Gao PJ; Gao J; Zhu JY
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
[TBL] [Abstract][Full Text] [Related]
18. Secondary Polycythemia and Non-Islet Cell Tumor-induced Hypoglycemia in Advanced Hepatocellular Carcinoma: A Case Report.
Paramitha MS; Esa DF; Hustrini NM; Mulansari NA; Hasan I; Harahap AS
Acta Med Indones; 2024 Jan; 56(1):93-101. PubMed ID: 38561874
[TBL] [Abstract][Full Text] [Related]
19. Clear cell hepatocellular carcinoma: sudden death from severe hypoglycemia.
Ross JS; Kurian S
Am J Gastroenterol; 1985 Mar; 80(3):188-94. PubMed ID: 2983534
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological study of juvenile hepatocellular carcinoma].
Furusawa A; Unoura M; Notsumata K; Morioka T; Hayakawa K; Matsushita E; Kobayashi K; Hattori N; Makino H; Fukuoka K
Nihon Shokakibyo Gakkai Zasshi; 1989 Dec; 86(12):2765-72. PubMed ID: 2483177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]